US › Healthcare

Jaguar Animal Health Inc (JAGX)

US · Healthcare · Biotechnology

$2.63-24.72%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.2M

Revenue YoY

-58.9%

Net profit

$-12.7M

EPS

$-15.70

EPS estimate

$-52.15

Net margin

-1,035.3%

EPS came in at -15.70 against a street estimate of -52.15 — a beat of 69.9%.

Key statistics

Market cap

$1.2M

P/E

0.0

Forward P/E

200.0

P/B

0.24

Book value

$1.36

EPS (TTM)

$98.20

52-week high

$8.00

52-week low

$0.22

50-day MA

$1.02

200-day MA

$13.36

Beta

-0.06

Analyst view

Analysts rate Jaguar Animal Health Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $262.50.

Shareholding

Insiders

8.16%

Institutions

0.10%

Largest institutional holders

Fund	Stake
UBS Group AG	0.07%
Geode Capital Management, LLC	0.06%
SBI Securities Co Ltd	0.00%
Tower Research Capital LLC	0.00%
Royal Bank of Canada	0.00%
LEONTEQ SECURITIES AG	0.00%
International Assets Investment Management, LLC	0.00%
BlackRock Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jaguar Animal Health Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.